Publications
Schandorff JM, Damgaard V, Little B, Kjærstad HL, Zarp J, Bjertrup AJ, Kessing LV, Knorr U, Vinberg M, Gallagher P, Miskowiak KW. Cognitive hierarchy in mood disorders and relations to daily functioning. J Affect Disord. 2025;375:239-48.
Miskowiak KW, Macoveanu J, Ozenne B, Beaman EE, Dam VH, Fisher PM, Knudsen GM, Kessing LV, Jørgensen MB, Frokjaer VG, Sankar A. Relation Between Brain Morphological Features and Psychiatric Hospitalization Risk in Major Depressive and Bipolar Disorders. Acta Psychiatr Scand. 2025.
Kjærstad HL, Ritsma F, Coello K, Stanislaus S, Munkholm K, Faurholt-Jepsen M, Macoveanu J, Bjertrup AJ, Vinberg M, Kessing LV, Miskowiak KW. Neural subgroups in unaffected first-degree relatives of patients with bipolar disorder during emotion regulation. Psychol Med. 2025;55:e45.
Jespersen AE, Lumbye A, Schandorff J, Damgaard V, Glenthoj LB, Nordentoft M, Mikkelsen C, Didriksen M, Ostrowski SR, Vinberg M, Waehrens EE, Miskowiak KW. Cognition Assessment in Virtual Reality (CAVIR): Associations with neuropsychological performance and activities of daily living in patients with mood or psychosis spectrum disorders. J Affect Disord. 2025;369:1053-63.
Damgaard V, Fortea L, Schandorff JM, Macoveanu J, Little B, Gallagher P, Knudsen GM, Kessing LV, Miskowiak KW. Multivariate patterns among multimodal neuroimaging and clinical, cognitive, and daily functioning characteristics in bipolar disorder. Neuropsychopharmacology. 2025.
Bjertrup AJ, Rasmussen KHE, Miskowiak KW. Psychological prevention of postpartum depression for expectant parents. J Affect Disord. 2025;378:58-73.
Thommesen KK, Damgaard V, Mariegaard J, Jespersen AE, Ysbæk-Nielsen AT, Mikkelsen C, Didriksen M, Ostrowski SR, Jørgensen MB, Macoveanu J, Miskowiak K. Neural underpinnings of memory encoding and retrieval: Validation of a novel ecologically valid fMRI paradigm Neuroscience Applied 2024 (in press).
Zarp J, Bruun CF, Christiansen ST, Krogh HB, Kuchinke OV, Bernsen CL, Jespersen AE, Bardram JE, Kessing LV, Miskowiak KW. Web-based cognitive screening in bipolar disorder: validation of the Internet-based Cognitive Assessment Tool in remote administration settings. Nord J Psychiatry. 2024:1-10.
Petersen JZ, Macoveanu J, Ysbaek-Nielsen AT, Kessing LV, Jorgensen MB, Miskowiak KW. Neural correlates of episodic memory decline following electroconvulsive therapy: An exploratory functional magnetic resonance imaging study. J Psychopharmacol. 2024;38(2):168-77.
Miskowiak KW, Roikjer TK, Mariegaard J, Bech JL, Obel ZK, Vejstrup B, Hansen L, Kessing LV. Implementing cognitive screenings for outpatients with bipolar disorder following optimised treatment in a specialised mood disorder clinic. Eur Neuropsychopharmacol. 2024;84:27-34.
Miskowiak KW, Petersen JZ, Macoveanu J, Ysbaek-Nielsen AT, Lindegaard IA, Cramer K, Mogensen MB, Hammershoj LG, Stougaard ME, Jorgensen JL, Schmidt LS, Vinberg M, Ehrenreich H, Hageman I, Videbech P, Gbyl K, Kellner CH, Kessing LV, Jorgensen MB. Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial. Eur Neuropsychopharmacol. 2024;79:38-48.
Miskowiak KW, Obel ZK, Guglielmo R, Bonnin CDM, Bowie CR, Balanza-Martinez V, Burdick KE, Carvalho AF, Dols A, Douglas K, Gallagher P, Kessing LV, Lafer B, Lewandowski KE, Lopez-Jaramillo C, Martinez-Aran A, McIntyre RS, Porter RJ, Purdon SE, Schaffer A, Stokes PRA, Sumiyoshi T, Torres IJ, Van Rheenen TE, Yatham LN, Young AH, Vieta E, Hasler G. Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force. Bipolar Disord. 2024;26(3):216-39.
Miskowiak KW, Kjaerstad HL. Can cognition screening in the clinic aid personalised treatment in bipolar disorder? Eur Neuropsychopharmacol. 2024;81:10-1.
Miskowiak KW, Damgaard V, Schandorff JM, Macoveanu J, Knudsen GM, Johansen A, Plaven-Sigray P, Svarer C, Fussing CB, Cramer K, Jorgensen MB, Kessing LV, Ehrenreich H. Effects of cognitive training under hypoxia on cognitive proficiency and neuroplasticity in remitted patients with mood disorders and healthy individuals: ALTIBRAIN study protocol for a randomized controlled trial. Trials. 2024;25(1):648.
Macoveanu J, Zarp Petersen J, Mariegaard J, Elleby Jespersen A, Cramer K, Fussing Bruun C, Østergaard Madsen H, Balslev Jørgensen Dmsc M, Vinberg Dmsc M, Fisher PM, Moos Knudsen G, Hageman I, Ehrenreich Dmsc H, Vedel Kessing Dmsc L, Woznica Miskowiak Dmsc K. Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial Running title: Treatment of cognitive impairment. 2024.
Macoveanu J, Zarp J, Vinberg M, Brendstrup-Brix K, Kessing LV, Jorgensen MB, Miskowiak KW. Exploring the effects of erythropoietin treatment on cortical thickness and hippocampal volume in patients with mood disorders undergoing electroconvulsive therapy: A randomized, placebo-controlled trial. J Psychopharmacol. 2024:2698811241301224.
Macoveanu J, Kjaerstad HL, Halvorsen KS, Fisher PM, Vinberg M, Kessing LV, Miskowiak KW. Trajectory of reward-related abnormalities in unaffected relatives of patients with bipolar disorder – A longitudinal fMRI study. J Psychiatr Res. 2024;170:217-24.
Macoveanu J, Fortea L, Kjaerstad HL, Coello K, Faurholt-Jepsen M, Fisher PM, Knudsen GM, Radua J, Vieta E, Frangou S, Vinberg M, Kessing LV, Miskowiak KW. Longitudinal changes in resting-state functional connectivity as markers of vulnerability or resilience in first-degree relatives of patients with bipolar disorder. Psychol Med. 2024:1-9.
Macoveanu J, Craciun S, Ketterer-Sykes EB, Ysbæk-Nielsen AT, Zarp J, Kessing LV, Jørgensen MB, Miskowiak KW. Amygdala and hippocampal substructure volumes and their association with improvement in mood symptoms in patients with mood disorders undergoing electroconvulsive therapy. Psychiatry Res Neuroimaging. 2024;343:111859.
Kjaerstad HL, Jespersen AE, Bech JL, Weidemann S, Bjertrup AJ, Jacobsen EH, Simonsen S, Glenthoj LB, Nordentoft M, Reveles K, Wobbe T, Lopes M, Lyngholm D, Miskowiak KW. Optimizing differential diagnostics and identifying transdiagnostic treatment targets using virtual reality. Eur Neuropsychopharmacol. 2024;92:1-9.
Kjaerstad HL, de Siqueira Rotenberg L, Macoveanu J, Coello K, Faurholt-Jepsen M, Bjertrup AJ, Knudsen GM, Fisher PM, Vinberg M, Kessing LV, Lafer B, Miskowiak KW. Stable neural underpinnings of emotional cognition subgroups in patients newly diagnosed with bipolar disorder: A prospective fMRI study. Bipolar Disord. 2024;26(6):556-69.
Jespersen AE, Obel Z, Lumbye A, Kessing LV, Miskowiak KW. Bipolar-ADHD comorbidity: screening for differences in neurocognition and virtual reality-based cognitive performance. Nord J Psychiatry. 2024;78(3):238-46.
Jespersen AE, Lumbye A, Vinberg M, Glenthoj L, Nordentoft M, Waehrens EE, Knudsen GM, Makransky G, Miskowiak KW. Effect of immersive virtual reality-based cognitive remediation in patients with mood or psychosis spectrum disorders: study protocol for a randomized, controlled, double-blinded trial. Trials. 2024;25(1):82.
Bjertrup AJ, Kofoed J, Egmose I, Wendelboe K, Southgate V, Vaever MS, Miskowiak KW. Prenatal affective cognitive training to reduce the risk of postpartum depression (PACT): study protocol for a randomized controlled trial. Trials. 2024;25(1):478.
Bjertrup AJ, Jahn FS, Schutt Hansen L, Miskowiak KW. Affective cognition in response to infant stimuli in pregnant compared with non-pregnant women. Women Health. 2024;64(5):427-39.
Sankar A, Ziersen SC, Ozenne B, Beaman EE, Dam VH, Fisher PM, Knudsen GM, Kessing LV, Frokjaer V, Miskowiak KW. Association of neurocognitive function with psychiatric hospitalization and socio-demographic conditions in individuals with bipolar and major depressive disorders. EClinicalMedicine. 2023;58:101927.
Miskowiak KW, Simonsen AH, Meyer M, Poulsen HE, Wilkan M, Forman J, Hasselbalch SG, Kessing LV, Knorr U. Cerebrospinal fluid erythropoietin, oxidative stress, and cognitive functions in patients with bipolar disorder and healthy control participants: A longitudinal case-control study. J Psychiatr Res. 2023;163:240-6.
Miskowiak KW, Pedersen JK, Gunnarsson DV, Roikjer TK, Podlekareva D, Hansen H, Dall CH, Johnsen S. Cognitive impairments among patients in a long-COVID clinic: Prevalence, pattern and relation to illness severity, work function and quality of life. J Affect Disord. 2023;324:162-9.
Miskowiak KW, Kjaerstad HL, Lemvigh CK, Ambrosen KS, Thorvald MS, Kessing LV, Glenthoj BY, Ebdrup BH, Fagerlund B. Neurocognitive subgroups among newly diagnosed patients with schizophrenia spectrum or bipolar disorders: A hierarchical cluster analysis. J Psychiatr Res. 2023;163:278-87.
Miskowiak KW, Hansen KB, Mariegaard J, Kessing LV. Association between childhood trauma, cognition, and psychosocial function in a large sample of partially or fully remitted patients with bipolar disorder and healthy participants. Int J Bipolar Disord. 2023;11(1):31.
Macoveanu J, Petersen JZ, Fisher PM, Kessing LV, Knudsen GM, Miskowiak KW. Associations between aberrant working memory-related neural activity and cognitive impairments in somatically healthy, remitted patients with mood disorders. Psychol Med. 2023;53(15):7203-13.
Macoveanu J, Mariegaard J, Petersen JZ, Fisher PM, Vinberg M, Jorgensen MB, Knudsen GM, Kessing LV, Miskowiak KW. Neural basis of memory impairments and relation to functional disability in fully or partially remitted patients with affective disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2023;125:110767.
Macoveanu J, Damgaard V, Ysbaek-Nielsen AT, Frangou S, Yatham LN, Chakrabarty T, Stougaard ME, Knudsen GM, Vinberg M, Kessing LV, Kjaerstad HL, Miskowiak KW. Early longitudinal changes in brain structure and cognitive functioning in remitted patients with recently diagnosed bipolar disorder. J Affect Disord. 2023;339:153-61.
Kjaerstad HL, Varo C, Meluken I, Vieta E, Vinberg M, Kessing LV, Miskowiak KW. Emotional cognition subgroups in unaffected first-degree relatives of patients with mood disorders. Psychol Med. 2023;53(6):2328-38.
Kjaerstad HL, Sohol K, Vinberg M, Kessing LV, Miskowiak KW. The trajectory of emotional and non-emotional cognitive function in newly diagnosed patients with bipolar disorder and their unaffected relatives: A 16-month follow-up study. Eur Neuropsychopharmacol. 2023;67:4-21.
Kjaerstad HL, Macoveanu J, Knudsen GM, Frangou S, Phan KL, Vinberg M, Kessing LV, Miskowiak KW. Neural responses during down-regulation of negative emotion in patients with recently diagnosed bipolar disorder and their unaffected relatives. Psychol Med. 2023;53(4):1254-65.
Kjaerstad HL, Haldorsen T, Vinberg M, Kessing LV, Miskowiak KW. Associations between emotional and non-emotional cognition and subsequent mood episodes in recently diagnosed patients with bipolar disorder: A 16-month follow-up study. J Affect Disord. 2023;324:16-23.
Jorgensen JL, Macoveanu J, Petersen JZ, Knudsen GM, Kessing LV, Jorgensen MB, Miskowiak KW. Association of childhood trauma with cognitive impairment and structural brain alterations in remitted patients with bipolar disorder. J Affect Disord. 2023;337:75-85.
Jespersen AE, Røen IS, Lumbye A, Nordentoft M, Glenthøj LB, Miskowiak KW. Feasibility and effect of an immersive virtual reality-based platform for cognitive training in real-life scenarios in patients with mood – or psychotic disorders: A randomized, controlled proof-of-concept study. Neuroscience Applied. 2023;2:101120-.
Fortea L, Ysbaek-Nielsen AT, Macoveanu J, Petersen JZ, Fisher PM, Kessing LV, Knudsen GM, Radua J, Vieta E, Miskowiak KW. Aberrant resting-state functional connectivity underlies cognitive and functional impairments in remitted patients with bipolar disorder. Acta Psychiatr Scand. 2023;148(6):570-82.
Ehrenreich H, Gassmann M, Poustka L, Burtscher M, Hammermann P, Siren AL, Nave KA, Miskowiak K. Exploiting moderate hypoxia to benefit patients with brain disease: Molecular mechanisms and translational research in progress. Neuroprotection. 2023;1(1):9-19.
de Siqueira Rotenberg L, Kjaerstad HL, Varo C, Vinberg M, Kessing LV, Lafer B, Miskowiak KW. The longitudinal trajectory of emotional cognition in subgroups of recently diagnosed patients with bipolar disorder. Eur Neuropsychopharmacol. 2023;71:9-24.
Damgaard V, Mariegaard J, Lindhardsen JM, Ehrenreich H, Miskowiak KW. Neuroprotective Effects of Moderate Hypoxia: A Systematic Review. Brain Sci. 2023;13(12).
Bjertrup AJ, Vaever MS, Miskowiak KW. Prediction of postpartum depression with an online neurocognitive risk screening tool for pregnant women. Eur Neuropsychopharmacol. 2023;73:36-47.
Bjertrup AJ, Petersen TH, Beier N, Kofoed J, Horgen IÅ, Kjærbye-Thygesen A, Kirkegaard T, Miskowiak KW. Prenatal affective cognitive training: A proof-of-concept study. Neuroscience Applied. 2023;2:101135-.
Zarp Petersen J, Varo C, Skovsen CF, Ott CV, Kjaerstad HL, Vieta E, Harmer CJ, Knudsen GM, Kessing LV, Macoveanu J, Miskowiak KW. Neuronal underpinnings of cognitive impairment in bipolar disorder: A large data-driven functional magnetic resonance imaging study. Bipolar Disord. 2022;24(1):69-81.
Nielsen SL, Ludwigsen T, Johnsen S, Miskowiak KW. [Cognitive late sequelae of COVID-19]. Ugeskr Laeger. 2022;184(15).
Mogensen MB, Macoveanu J, Knudsen GM, Ott CV, Miskowiak KW. Influence of pre-treatment structural brain measures on effects of action-based cognitive remediation on executive function in partially or fully remitted patients with bipolar disorder. Eur Neuropsychopharmacol. 2022;56:50-9.
Miskowiak KW, Yalin N, Seeberg I, Burdick KE, Balanza-Martinez V, Bonnin CDM, Bowie CR, Carvalho AF, Dols A, Douglas K, Gallagher P, Hasler G, Kessing LV, Lafer B, Lewandowski KE, Lopez-Jaramillo C, Martinez-Aran A, McIntyre RS, Porter RJ, Purdon SE, Schaffer A, Sumiyoshi T, Torres IJ, Van Rheenen TE, Yatham LN, Young AH, Vieta E, Stokes PRA. Can magnetic resonance imaging enhance the assessment of potential new treatments for cognitive impairment in mood disorders? A systematic review and position paper by the International Society for Bipolar Disorders Targeting Cognition Task Force. Bipolar Disord. 2022;24(6):615-36.
Miskowiak KW, Seeberg I, Jensen MB, Balanza-Martinez V, Del Mar Bonnin C, Bowie CR, Carvalho AF, Dols A, Douglas K, Gallagher P, Hasler G, Lafer B, Lewandowski KE, Lopez-Jaramillo C, Martinez-Aran A, McIntyre RS, Porter RJ, Purdon SE, Schaffer A, Stokes P, Sumiyoshi T, Torres IJ, Van Rheenen TE, Yatham LN, Young AH, Kessing LV, Burdick KE, Vieta E. Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force. Bipolar Disord. 2022;24(4):354-74.
Miskowiak KW, Mariegaard J, Jahn FS, Kjaerstad HL. Associations between cognition and subsequent mood episodes in patients with bipolar disorder and their unaffected relatives: A systematic review. J Affect Disord. 2022;297:176-88.
Miskowiak KW, Fugledalen L, Jespersen AE, Sattler SM, Podlekareva D, Rungby J, Porsberg CM, Johnsen S. Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: Pattern, severity, and functional implications. Eur Neuropsychopharmacol. 2022;59:82-92.
Miskowiak KW, Bech JL, Henriksen AC, Johnsen S, Podlekareva D, Marner L. Cerebral Metabolic Rate of Glucose and Cognitive Tests in Long COVID Patients. Brain Sci. 2022;13(1).
Macoveanu J, Stougaard ME, Kjaerstad HL, Knudsen GM, Vinberg M, Kessing LV, Miskowiak KW. Trajectory of aberrant reward processing in patients with bipolar disorder – A longitudinal fMRI study. J Affect Disord. 2022;312:235-44.
Macoveanu J, Damgaard V, Ott CV, Knudsen GM, Kessing LV, Miskowiak KW. Action-based cognitive remediation in bipolar disorder improved verbal memory but had no effect on the neural response during episodic memory encoding. Psychiatry Res Neuroimaging. 2022;319:111418.
Kjaerstad HL, Poulsen E, Vinberg M, Kessing LV, Miskowiak KW. Differential trajectory of cognitive functions in neurocognitive subgroups of newly diagnosed patients with bipolar disorder and their unaffected first-degree relatives – A longitudinal study. J Affect Disord. 2022;311:115-25.
Kjaerstad HL, Hellum KS, Haslum NH, Lopes MN, Noer TS, Kessing LV, Miskowiak KW. Assessment of the validity and feasibility of a novel virtual reality test of emotion regulation in patients with bipolar disorder and their unaffected relatives. J Affect Disord. 2022;318:217-23.
Kjaerstad HL, de Siqueira Rotenberg L, Knudsen GM, Vinberg M, Kessing LV, Macoveanu J, Lafer B, Miskowiak KW. The longitudinal trajectory of emotion regulation and associated neural activity in patients with bipolar disorder: A prospective fMRI study. Acta Psychiatr Scand. 2022;146(6):568-82.
Kjaerstad HL, Damgaard V, Knudsen GM, Vinberg M, Kessing LV, Macoveanu J, Miskowiak KW. Neural underpinnings of emotion regulation subgroups in remitted patients with recently diagnosed bipolar disorder. Eur Neuropsychopharmacol. 2022;60:7-18.
Horlyck LD, Jespersen AE, King JA, Ullum H, Miskowiak KW. Impaired allocentric spatial memory in patients with affective disorders. J Psychiatr Res. 2022;150:153-9.
Hammershoj LG, Petersen JZ, Jensen HM, Jorgensen MB, Miskowiak KW. Cognitive Adverse Effects of Electroconvulsive Therapy: A Discrepancy Between Subjective and Objective Measures? J ECT. 2022;38(1):30-8.
Douglas KM, Strawbridge R, Miskowiak KW. Can biomarkers aid the stratification of individuals with mood disorders for cognitive remediation interventions? Bipolar Disord. 2022;24(6):571-3.
Bjertrup A, Macoveanu J, Laurent H, Moszkowicz M, Finnegan MK, Egmose I, Fisher PM, Nielsen RE, Pagsberg AK, Kessing LV, Vaever M, Miskowiak K. Reduced prefrontal cortex response to own vs. unknown emotional infant faces in mothers with bipolar disorder. Eur Neuropsychopharmacol. 2022;54:7-20.
Varo C, Kjaerstad HL, Poulsen E, Meluken I, Vieta E, Kessing LV, Vinberg M, Miskowiak KW. Emotional cognition subgroups in mood disorders: Associations with familial risk. Eur Neuropsychopharmacol. 2021;51:71-83.
Seeberg I, Nielsen IB, Jorgensen CK, Eskestad ND, Miskowiak KW. Effects of psychological and pharmacological interventions on anxiety symptoms in patients with bipolar disorder in full or partial remission: A systematic review. J Affect Disord. 2021;279:31-45.
Petersen JZ, Macoveanu J, Kjaerstad HL, Knudsen GM, Kessing LV, Miskowiak KW. Assessment of the neuronal underpinnings of cognitive impairment in bipolar disorder with a picture encoding paradigm and methodological lessons learnt. J Psychopharmacol. 2021;35(8):983-91.
Petersen CS, Miskowiak KW. Toward a transdiagnostic neurocircuitry-based biomarker model for pro-cognitive effects: challenges, opportunities, and next steps. CNS Spectr. 2021;26(4):333-7.
Ott CV, Vinberg M, Kessing LV, Bowie CR, Forman JL, Miskowiak KW. Effect of Action-Based Cognitive Remediation on cognitive impairment in patients with remitted bipolar disorder: A randomized controlled trial. Bipolar Disord. 2021;23(5):487-99.
Ott CV, Macoveanu J, Bowie CR, Fisher PM, Knudsen GM, Kessing LV, Miskowiak KW. Change in prefrontal activity and executive functions after action-based cognitive remediation in bipolar disorder: a randomized controlled trial. Neuropsychopharmacology. 2021;46(6):1113-21.
Ott CV, Knorr U, Jespersen A, Obenhausen K, Roen I, Purdon SE, Kessing LV, Miskowiak KW. Norms for the Screen for Cognitive Impairment in Psychiatry and cognitive trajectories in bipolar disorder. J Affect Disord. 2021;281:33-40.
Miskowiak KW, Varo C. Social cognition in bipolar disorder: A proxy of psychosocial function and novel treatment target? Eur Neuropsychopharmacol. 2021;46:37-8.
Miskowiak KW, Moller AB, Ott CV. Neuronal and cognitive predictors of improved executive function following action-based cognitive remediation in patients with bipolar disorder. Eur Neuropsychopharmacol. 2021;47:1-10.
Miskowiak KW, Johnsen S, Sattler SM, Nielsen S, Kunalan K, Rungby J, Lapperre T, Porsberg CM. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39-48.
Miskowiak KW, Jespersen AE, Obenhausen K, Hafiz P, Hestbaek E, Gulyas L, Kessing LV, Bardram JE. Internet-based cognitive assessment tool: Sensitivity and validity of a new online cognition screening tool for patients with bipolar disorder. J Affect Disord. 2021;289:125-34.
Miskowiak KW, Jespersen AE, Kessing LV, Aggestrup AS, Glenthoj LB, Nordentoft M, Ott CV, Lumbye A. Cognition Assessment in Virtual Reality: Validity and feasibility of a novel virtual reality test for real-life cognitive functions in mood disorders and psychosis spectrum disorders. J Psychiatr Res. 2021;145:182-9.
Macoveanu J, Meluken I, Kessing LV, Siebner HR, Vinberg M, Miskowiak KW. Hippocampal subfield morphology in monozygotic twins discordant for affective disorders. Neuropsychopharmacology. 2021;46(3):561-8.
Macoveanu J, Meluken I, Chase HW, Phillips ML, Kessing LV, Siebner HR, Vinberg M, Miskowiak KW. Reduced frontostriatal response to expected value and reward prediction error in remitted monozygotic twins with mood disorders and their unaffected high-risk co-twins. Psychol Med. 2021;51(10):1637-46.
Macoveanu J, Kjaerstad HL, Vinberg M, Harmer C, Fisher PM, Knudsen GM, Kessing LV, Miskowiak KW. Affective episodes in recently diagnosed patients with bipolar disorder associated with altered working memory-related prefrontal cortex activity: A longitudinal fMRI study. J Affect Disord. 2021;295:647-56.
Macoveanu J, Freeman KO, Kjaerstad HL, Knudsen GM, Kessing LV, Miskowiak KW. Structural brain abnormalities associated with cognitive impairments in bipolar disorder. Acta Psychiatr Scand. 2021;144(4):379-91.
Kjaerstad HL, Eikeseth FF, Vinberg M, Kessing LV, Miskowiak K. Neurocognitive heterogeneity in patients with bipolar disorder and their unaffected relatives: associations with emotional cognition. Psychol Med. 2021;51(4):668-79.
Jensen MB, Kjaerstad HL, Coello K, Stanislaus S, Melbye S, Sletved KO, Vinberg M, Kessing LV, Miskowiak KW. Affective and non-affective cognition in patients with bipolar disorder type I and type II in full or partial remission: Associations with familial risk. J Affect Disord. 2021;283:207-15.
Jahn FS, Skovbye M, Obenhausen K, Jespersen AE, Miskowiak KW. Cognitive training with fully immersive virtual reality in patients with neurological and psychiatric disorders: A systematic review of randomized controlled trials. Psychiatry Res. 2021;300:113928.
Horlyck LD, Obenhausen K, Jansari A, Ullum H, Miskowiak KW. Virtual reality assessment of daily life executive functions in mood disorders: associations with neuropsychological and functional measures. J Affect Disord. 2021;280(Pt A):478-87.
Ehrenreich H, Neubauer AP, Miskowiak K. Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years. JAMA. 2021;325(14):1470-1.
Bjertrup AJ, Moszkowicz M, Egmose I, Kjaerbye-Thygesen A, Nielsen RE, Parsons CE, Kessing LV, Pagsberg AK, Vaever MS, Miskowiak KW. Processing of infant emotion in mothers with mood disorders and implications for infant development. Psychol Med. 2021;52(16):1-11.
Bjertrup AJ, Jensen MB, Schjodt MS, Parsons CE, Kjaerbye-Thygesen A, Mikkelsen RL, Moszkowicz M, Frokjaer VG, Vinberg M, Kessing LV, Vaever MS, Miskowiak KW. Cognitive processing of infant stimuli in pregnant women with and without affective disorders and the association to postpartum depression. Eur Neuropsychopharmacol. 2021;42:97-109.
Bjertrup A, Friis N, Vaever M, Miskowiak K. Neurocognitive processing of infant stimuli in mothers and non-mothers: psychophysiological, cognitive and neuroimaging evidence. Soc Cogn Affect Neurosci. 2021;16(4):428-38.
Vestergaard M, Kongerslev MT, Thomsen MS, Mathiesen BB, Harmer CJ, Simonsen E, Miskowiak KW. Women With Borderline Personality Disorder Show Reduced Identification of Emotional Facial Expressions and a Heightened Negativity Bias. J Pers Disord. 2020;34(5):677-98.
Reinholdt-Dunne ML, Seeberg I, Blicher A, Normann N, Vinberg M, Kessing LV, Miskowiak KW. Residual Anxiety in Patients with Bipolar Disorder in Full or Partial Remission: Metacognitive Beliefs and Neurocognitive Function. Cognitive Therapy and Research. 2020;45(1):179-89.
Miskowiak KW, Lewandowski KE. Trajectory of cognitive functions in bipolar disorder: for better or worse? Acta Psychiatr Scand. 2020;141(2):95-7.
Miskowiak KW, Forman JL, Vinberg M, Siebner HR, Kessing LV, Macoveanu J. Impact of pretreatment interhemispheric hippocampal asymmetry on improvement in verbal learning following erythropoietin treatment in mood disorders: a randomized controlled trial. J Psychiatry Neurosci. 2020;45(3):198-205.
Miskowiak KW. Erythropoietin as possible treatment of brain diseases. Ugeskrift for læger. 2020;182(44).
Macoveanu J, Kjaerstad HL, Chase HW, Frangou S, Knudsen GM, Vinberg M, Kessing LV, Miskowiak KW. Abnormal prefrontal cortex processing of reward prediction errors in recently diagnosed patients with bipolar disorder and their unaffected relatives. Bipolar Disord. 2020;22(8):849-59.
Kjaerstad HL, Jorgensen CK, Broch-Due I, Kessing LV, Miskowiak K. Eye gaze and facial displays of emotion during emotional film clips in remitted patients with bipolar disorder. Eur Psychiatry. 2020;63(1):e29.
Ehrenreich H, Weissenborn K, Begemann M, Busch M, Vieta E, Miskowiak KW. Erythropoietin as candidate for supportive treatment of severe COVID-19. Mol Med. 2020;26(1):58.
Ehrenreich H, Neubauer AP, Miskowiak K. Erythropoietin in Preterm Infants. N Engl J Med. 2020;382(19):1862.
Vinberg M, Ottesen NM, Meluken I, Sorensen N, Pedersen O, Kessing LV, Miskowiak KW. Remitted affective disorders and high familial risk of affective disorders associate with aberrant intestinal microbiota. Acta Psychiatr Scand. 2019;139(2):174-84.
Petersen JZ, Porter RJ, Miskowiak KW. Clinical characteristics associated with the discrepancy between subjective and objective cognitive impairment in depression. J Affect Disord. 2019;246:763-74.
Petersen JZ, Nilsson M, Rungby J, Miskowiak KW. Characteristics influencing expected cognitive performance during hypoglycaemia in type 2 diabetes. Psychoneuroendocrinology. 2019;110:104431.
Ott CV, Vinberg M, Bowie CR, Christensen EM, Knudsen GM, Kessing LV, Miskowiak KW. Correction to: Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial. Trials. 2019;20(1):201.
Ott CV, Johnson CB, Macoveanu J, Miskowiak K. Structural changes in the hippocampus as a biomarker for cognitive improvements in neuropsychiatric disorders: A systematic review. Eur Neuropsychopharmacol. 2019;29(3):319-29.
Ott C, Mine H, Petersen JZ, Miskowiak K. Relation between functional and cognitive impairments in remitted patients with bipolar disorder and suggestions for trials targeting cognition: An exploratory study. J Affect Disord. 2019;257:382-9.
Nielsen SFV, Madsen KH, Vinberg M, Kessing LV, Siebner HR, Miskowiak KW. Whole-Brain Exploratory Analysis of Functional Task Response Following Erythropoietin Treatment in Mood Disorders: A Supervised Machine Learning Approach. Front Neurosci. 2019;13:1246.
Miskowiak KW, Seeberg I, Kjaerstad HL, Burdick KE, Martinez-Aran A, Del Mar Bonnin C, Bowie CR, Carvalho AF, Gallagher P, Hasler G, Lafer B, Lopez-Jaramillo C, Sumiyoshi T, McIntyre RS, Schaffer A, Porter RJ, Purdon S, Torres IJ, Yatham LN, Young AH, Kessing LV, Van Rheenen TE, Vieta E. Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force. Bipolar Disord. 2019;21(8):686-719.
Miskowiak KW, Petersen CS. Neuronal underpinnings of cognitive impairment and – improvement in mood disorders. CNS Spectr. 2019;24(1):30-53.
Miskowiak K, Gjerullf-Hansen C, Jensen M, Nielsen S, Ott C. [Assessment and treatment of cognitive impairments in patients with affective disorders]. Ugeskr Laeger. 2019;181(45).
Meluken I, Ottesen NM, Phan KL, Goldin PR, Di Simplicio M, Macoveanu J, Siebner HR, Kessing LV, Vinberg M, Miskowiak KW. Neural response during emotion regulation in monozygotic twins at high familial risk of affective disorders. Neuroimage Clin. 2019;21:101598.
Meluken I, Ottesen NM, Harmer CJ, Scheike T, Kessing LV, Vinberg M, Miskowiak KW. Is aberrant affective cognition an endophenotype for affective disorders? – A monozygotic twin study. Psychol Med. 2019;49(6):987-96.
Meluken I, Ottesen N, Harmer C, Macoveanu J, Siebner H, Kessing L, Vinberg M, Miskowiak K. Neural response to emotional faces in monozygotic twins: association with familial risk of affective disorders. J Psychiatry Neurosci. 2019;44(4):277-86.
Horlyck LD, Macoveanu J, Vinberg M, Kessing LV, Siebner HR, Miskowiak KW. The BDNF Val66Met Polymorphism Has No Effect on Encoding-Related Hippocampal Response But Influences Recall in Remitted Patients With Bipolar Disorder. Front Psychiatry. 2019;10:845.
Di Simplicio M, Lau-Zhu A, Meluken I, Taylor P, Kessing LV, Vinberg M, Holmes EA, Miskowiak KW. Emotional Mental Imagery Abnormalities in Monozygotic Twins With, at High-Risk of, and Without Affective Disorders: Present in Affected Twins in Remission but Absent in High-Risk Twins. Front Psychiatry. 2019;10:801.
Bjertrup AJ, Friis NK, Miskowiak KW. The maternal brain: Neural responses to infants in mothers with and without mood disorder. Neurosci Biobehav Rev. 2019;107:196-207.
Vinberg M, Hojman P, Pedersen BK, Kessing LV, Miskowiak KW. Effects of erythropoietin on body composition and fat-glucose metabolism in patients with affective disorders. Acta Neuropsychiatr. 2018;30(6):342-9.
Seeberg I, Kjaerstad HL, Miskowiak KW. Neural and Behavioral Predictors of Treatment Efficacy on Mood Symptoms and Cognition in Mood Disorders: A Systematic Review. Front Psychiatry. 2018;9:337.
Schmidt LS, Petersen JZ, Vinberg M, Hageman I, Olsen NV, Kessing LV, Jorgensen MB, Miskowiak KW. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial. Trials. 2018;19(1):234.
Petersen JZ, Schmidt LS, Vinberg M, Jorgensen MB, Hageman I, Ehrenreich H, Knudsen GM, Kessing LV, Miskowiak KW. Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial. Trials. 2018;19(1):611.
Petersen JZ, Miskowiak KW. [Cognitive side effects of electroconvulsive therapy]. Ugeskr Laeger. 2018;180(18).
Ott CV, Vinberg M, Bowie CR, Christensen EM, Knudsen GM, Kessing LV, Miskowiak KW. Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial. Trials. 2018;19(1):487.
Miskowiak KW, Petersen NA, Harmer CJ, Ehrenreich E, Kessing LV, Vinberg M, Macoveanu J, Siebner HR. Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder. Acta Psychiatr Scand. 2018;138(4):336-47.
Miskowiak KW, Macoveanu J, Jorgensen MB, Stottrup MM, Ott CV, Jensen HM, Jorgensen A, Harmer J, Paulson OB, Kessing LV, Siebner HR. Neural Response After a Single ECT Session During Retrieval of Emotional Self-Referent Words in Depression: A Randomized, Sham-Controlled fMRI Study. Int J Neuropsychopharmacol. 2018;21(3):226-35.
Miskowiak KW, Macoveanu J, Jorgensen MB, Ott CV, Stottrup MM, Jensen HM, Jorgensen A, Harmer CJ, Paulson OB, Siebner HR, Kessing LV. Effect of electroconvulsive therapy on neural response to affective pictures: A randomized, sham-controlled fMRI study. Eur Neuropsychopharmacol. 2018;28(8):915-24.
Miskowiak KW, Larsen JE, Harmer CJ, Siebner HR, Kessing LV, Macoveanu J, Vinberg M. Is negative self-referent bias an endophenotype for depression? An fMRI study of emotional self-referent words in twins at high vs. low risk of depression. J Affect Disord. 2018;226:267-73.
Miskowiak KW, Burdick KE, Martinez-Aran A, Bonnin CM, Bowie CR, Carvalho AF, Gallagher P, Lafer B, Lopez-Jaramillo C, Sumiyoshi T, McIntyre RS, Schaffer A, Porter RJ, Purdon S, Torres IJ, Yatham LN, Young AH, Kessing LV, Vieta E. Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians. Bipolar Disord. 2018;20(3):184-94.
Macoveanu J, Demant KM, Vinberg M, Siebner HR, Kessing LV, Miskowiak KW. Towards a biomarker model for cognitive improvement: No change in memory-related prefrontal engagement following a negative cognitive remediation trial in bipolar disorder. J Psychopharmacol. 2018;32(10):1075-85.
Kessing LV, Miskowiak K. Does Cognitive Dysfunction in Bipolar Disorder Qualify as a Diagnostic Intermediate Phenotype?-A Perspective Paper. Front Psychiatry. 2018;9:490.
Kaersgaard S, Meluken I, Kessing LV, Vinberg M, Miskowiak KW. Increased sensitivity to positive social stimuli in monozygotic twins at risk of bipolar vs. unipolar disorder. J Affect Disord. 2018;232:212-8.
Inkster B, Zai G, Lewis G, Miskowiak KW. GSK3beta: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders? Transl Psychiatry. 2018;8(1):216.
Broch-Due I, Kjaerstad HL, Kessing LV, Miskowiak K. Subtle behavioural responses during negative emotion reactivity and down-regulation in bipolar disorder: A facial expression and eye-tracking study. Psychiatry Res. 2018;266:152-9.